Posts by: Marisa Wexler, MS

Marisa Wexler, MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

January 7, 2020January 7, 2020

New Questionnaire Measures Patients’ View of Disease Control in Recurrent Angioedema

News

Researchers developed a questionnaire, called the Angioedema Control Test (AECT), that may be helpful in monitoring disease control and patient-reported outcomes among people with recurrent angioedema. The tool is ... Read more

December 19, 2019December 20, 2019

Study Validates Thai Version of Angioedema Quality of Life Questionnaire

News

A Thai version of the Angioedema Quality of Life (AE-QoL) questionnaire is a reliable way to measure health-related quality of life in Asian people with recurrent angioedema, a new ... Read more

October 10, 2019

Mutation Detection Method Cheaper, Quicker for HAE Diagnosis Than Sequencing, Study Says

News

A genetic technique called allelic discrimination — which detects a specific variant of the F12 gene — might make diagnosing certain hereditary angioedema-causing mutations quicker and cheaper, a new ... Read more

August 22, 2019August 22, 2019

New Rat Model of HAE More Closely Mimics Human Disease

News

Researchers have developed a new rat model of hereditary angioedema (HAE) that more closely mimics the swelling episodes experienced by humans, which might improve studies about the mechanisms that ... Read more

July 25, 2019

Guidelines Compiled for Diagnosing HAE in Emergency Rooms

News

In a new study, researchers provide recommendations for when to consider a diagnosis of hereditary angioedema (HAE) for patients who come to the emergency room with swelling. The study, ... Read more

March 28, 2019

Haegarda Safe, Effective in the Long-term for Preventing Hereditary Angioedema Attacks, Study Finds

News

Haegarda, a concentrated form of C1 inhibitor (C1-INH), is safe and effectively helps to prevent hereditary angioedema attacks in the long-term, allowing patients to become free of disease symptoms, That is ... Read more

January 17, 2019

Mutant C1 Inhibitor Traps Healthy C1 Inhibitor in Cells of HAE Patients, Study Shows

News

Some mutations in the SERPING1 gene that cause hereditary angioedema (HAE) result in an abnormal form of the C1 inhibitor (C1-INH) that binds to and traps healthy C1-INH in cells, severely reducing ... Read more

January 10, 2019

Canadian Physicians Need More Info About Hereditary Angioedema Tests, Study Finds

News

Physicians in Canada need better education about the multiple biological assays used to diagnose hereditary angioedema caused by C1 inhibitor deficiency (C1-INH-HAE), which will increase their confidence and access to ... Read more

Pin It on Pinterest